We identified no clinical confounders between DCM-pRV/DCM-RVF, ICM-pRV/ICM-RVF, and combined pRV/RVF groups (Table 1 and Supplementary Table 2), including no differences in gender, age, ethnicity, body surface area, body weight, heart weight, renal function by glomerular filtration rate, diabetes, use of reverse remodeling agents collectively or individually (ACE inhibitor, angiotensin receptor blocker, or β-blocker), use of other cardioactive medications (digoxin, diuretics, calcium channel blockers, or milrinone), lipid lowering medications, thyroid medications, or pacemakers. The gene discussed is ACE; the disease is thyroid gland disorder.